<DOC>
	<DOCNO>NCT01020344</DOCNO>
	<brief_summary>A randomise control trial perform evaluate effect lung volume reduction surgery ( LVRS ) patient COPD systemic inflammation , oxidative stress , endothelial function , arterial stiffness blood pressure . We hypothesize LVRS lead reduction systemic inflammation , oxidative stress , arterial stiffness blood pressure improve endothelial function . For purpose 30 patient severe/very severe COPD ( GOLD III-IV ) pulmonary emphysema undergo LVRS randomise one two group : group 1 receive immediate LVRS group 2 receive LVRS delay 3 month . Measures systemic inflammation , oxidative stress , endothelial function , arterial stiffness blood pressure measure baseline 3 month surgery surgery , respectively ( group 2 receiving surgery delay 3 month serve control group ) investigate effect LVRS describe outcome .</brief_summary>
	<brief_title>Mechanisms Vascular Damage Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Not desire</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion : Dyspnea rest minimal physical activity , severe limitation exercise capacity ( 6min walk distance &lt; 350 ) . Acceptance increase perioperative mortality ( approximately 2 % ) and/or morbidity ( long lasting hospitalization due prolong air leak ) COPD ( GOLD guideline ) severe obstructive ventilatory defect ( FEV1 &lt; 35 % predict ) Functional aspect lung emphysema , i.e . irreversible hyperinflation residual volume total lung capacity ratio ( RV/TLC ) &gt; 0.65 impaired total lung diffusion capacity ( DLCO ) , usually &lt; 40 % predict . Pulmonary emphysema confirm high resolution computer tomography Exclusion criterion : Current smoker Age &gt; 75years `` Vanishing '' lung diffuse lung emphysema CT , FEV1 &lt; 20 % predict DLCO &lt; 20 % predict , hypercapnia ( PaCO2 &gt; 7.3kPa ) Overt active coronary artery disease , severe leave ventricular function impairment Pulmonary hypertension mean pulmonary artery pressure &gt; 35 mmHg rest Acute bronchopulmonary infection , bronchiectasis high resolution tomography Pulmonary cachexia ( body mass index &lt; 18kg/m2 ) Neoplastic disease life expectancy le 2 year Addiction alcohol/drugs Relevant renal ( creatinine &gt; 150ug/ml ) , active gastroenterological ( GIbleeding previous year , abnormal liver function , active inflammatory bowel disease ) active neurological disease .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>